Item 5. Other Information
Item 5. Other Information
None
20
Table of Contents
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report.
No.
Description of
Exhibit
2.1(1)
Business Combination Agreement, dated as of January 18, 2022
3.1(2)
Amended and Restated Memorandum and Articles of Association of the Registrant.
10.1(3)
Form of Subscription Agreement for Institutional Investors
10.2(4)
Form of Subscription Agreement for Individual Investors
10.3(5)
Sponsor Support Agreement, dated as of January 18, 2022
10.4(6)
ProKidney Unitholder Support Agreement, dated as of January 18, 2022
31.1*
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*
INLINE XBRL Instance Document
101.SCH*
INLINE XBRL Taxonomy Extension Schema Document
101.CAL*
INLINE XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*
INLINE XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
INLINE XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*
INLINE XBRL Taxonomy Extension Presentation Linkbase Document
104*
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
(1)
Incorporated by reference to Exhibit 2.1 to Amendment No. 1 to the Registrant’s Current Report on Form 8-K
filed on January 21, 2022. Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K
Item 601(b)(2). The registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.
(2)
Incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K
filed on July 2, 2021.
(3)
Incorporated by reference to Exhibit 10.1 to Amendment No. 1 to the Registrant’s Current Report on Form 8-K
filed on January 21, 2022.
(4)
Incorporated by reference to Exhibit 10.2 to Amendment No. 1 to the Registrant’s Current Report on Form 8-K
filed on January 21, 2022.
(5)
Incorporated by reference to Exhibit 10.3 to Amendment No. 1 to the Registrant’s Current Report on Form 8-K
filed on January 21, 2022.
(6)
Incorporated by reference to Exhibit 10.4 to Amendment No. 1 to the Registrant’s Current Report on Form 8-K
filed on January 21, 2022.
21
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. III
Date: May 16, 2022
By:
/s/ Chamath Palihapitiya
Name:
Chamath Palihapitiya
Title:
Chief Executive Officer
(Principal Executive Officer)
Date: May 16, 2022
By:
/s/ James Ryans
Name:
James Ryans
Title:
Chief Financial Officer
(Principal Financial and Accounting Officer)
22
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.